3-[({2-[(1R,8S,9R)-bicyclo[6.1.0]non-4-yn-9-yl]ethoxy}[bis(propan-2-yl)amino]phosphanyl)oxy]propanenitrile
Structure Info
- Chemspace ID
- CSCS02515442276 (Synthesis)
- CAS
- 1393524-83-8
- IUPAC Name
- 3-[({2-[(1R,8S,9R)-bicyclo[6.1.0]non-4-yn-9-yl]ethoxy}[bis(propan-2-yl)amino]phosphanyl)oxy]propanenitrile
- Mol formula
- C20H33N2O2P
- Mol weight
- 364 Da
- Catalog Number(s)
- AA0EXUUS, AG0EXUXK, AR0EXVMK, BD02571580, C576255, CS-1181164, F556797, H36228, HY-W714969A, JQ94160, OR1034459, SY483220
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.86
- Heavy atoms count
- 25
- Rotatable bond count
- 10
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.85
- Polar surface area (Å)
- 45
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 0
- Zoom the structure
- CSCS02515442276
Items Overall 17 items from 8 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| ChemScene LLC | 5 days | United States To: | 96 | 100 mg | 1,645.00 | |
| ChemScene LLC | 5 days | United States To: | 96 | 250 mg | 2,740.00 | |
Description: BCN-CE-phosphoramidite; CAS: 1393524-83-8 | ||||||
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 5 mg | 192.00 | |
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 10 mg | 290.00 | |
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 25 mg | 561.00 | |
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 100 mg | 1,462.00 | |
Description: Name:2-((1α,8α,9β)-Bicyclo[6.1.0]non-4-yn-9-yl)ethyl (2-cyanoethyl) diisopropylphosphoramidite; CAS: 1393524-83-8 | ||||||
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 5 mg | 192.00 | |
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 10 mg | 290.00 | |
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 25 mg | 561.00 | |
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 100 mg | 1,462.00 | |
Description: Name:2-((1α,8α,9β)-Bicyclo[6.1.0]non-4-yn-9-yl)ethyl (2-cyanoethyl) diisopropylphosphoramidite; CAS: 1393524-83-8 | ||||||
| Angene US | 40 days | United States To: | 96 | 25 mg | 430.20 | |
| Angene US | 40 days | United States To: | 96 | 100 mg | 1,107.90 | |
| Angene US | 40 days | United States To: | 96 | 250 mg | 1,918.80 | |
Description: 2-((1α,8α,9β)-Bicyclo[6.1.0]non-4-yn-9-yl)ethyl (2-cyanoethyl) diisopropylphosphoramidite; CAS: 1393524-83-8 | ||||||
| Astatech CN | 40 days | China To: | 95 | 25 mg | 1,898.60 | |
Description: 2-((1ALPHA,8ALPHA,9BETA)-BICYCLO[6.1.0]NON-4-YN-9-YL)ETHYL (2-CYANOETHYL) DIISOPROPYLPHOSPHORAMIDITE; CAS: 1393524-83-8 | ||||||
| Astatech Inc | 40 days | United States To: | 95 | 25 mg | 1,898.60 | |
Description: 2-((1ALPHA,8ALPHA,9BETA)-BICYCLO[6.1.0]NON-4-YN-9-YL)ETHYL (2-CYANOETHYL) DIISOPROPYLPHOSPHORAMIDITE; CAS: 1393524-83-8 | ||||||
| MedChemExpress | TBD | United States To: | 90 | 1 mg | POA | |
Description: Names: BCN-CE-phosphoramidite; Product Description: BCN-CE-phosphoramidite is an oligonucleotide modifier containing a BCN strained cyclooctyne structure. BCN-CE-phosphoramidite possesses bioorthogonal reactivity and bioconjugation capability; CAS: 1393524-83-8 | ||||||
| MedChemExpress EU | TBD | Sweden To: | 90 | 1 mg | POA | |
Description: Names: BCN-CE-phosphoramidite; Product Description: BCN-CE-phosphoramidite is an oligonucleotide modifier containing a BCN strained cyclooctyne structure. BCN-CE-phosphoramidite possesses bioorthogonal reactivity and bioconjugation capability; CAS: 1393524-83-8 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire